NCPE chief under fire for his 'cost-effectiveness' comment on life-saving drugs
Prof Michael Barry, the clinical director for the National Centre for Pharmacoeconomics (NCPE), made his 'value for money' comment on RTÉ on Sunday. File picture: Shane O'Neill/Coalesce
Comments by the head of the committee that recommends to the HSE whether new drugs should be approved or not, about survival rates versus cost effectiveness, were "inappropriate" and caused "disgust" among campaigners, an Oireachtas committee has heard.
Director of the National Centre for Pharmacoeconomics (NCPE) Professor Michael Barry told RTÉ Radio 1's on Sunday that he is opposed to early access to a new drug on a cost-effectiveness basis.




